Showing results (31-40 of 929) with videos related to
Sort By:
Pageof 93
Journal of Drugs in Dermatology : JDD|October 31, 2007
Conversion to positive tuberculosis test during etanercept treatment of psoriasisWilliam Sumner, Steven R FeldmanJournal of the American Academy of Dermatology|September 22, 2007
Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatmentsJeff Hick, Steven R FeldmanDrugs in Context|January 20, 2015
The cost of biologics for psoriasis is increasingJudy Cheng, Steven R FeldmanCutis|June 8, 2011
Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implicationsSteven R Feldman, Alan B FleischerJournal of Drugs in Dermatology : JDD|June 23, 2009
Are ointments better than other vehicles for corticosteroid treatment of psoriasis?Anna H Zivkovich, Steven R FeldmanExpert Opinion on Pharmacotherapy|January 26, 2006
Cost-effectiveness of moderate-to-severe psoriasis treatmentDrew W Miller, Steven R FeldmanJournal of Cutaneous Medicine and Surgery|December 16, 2024
Indoor Tanning Addiction: Biological Mechanisms and Association with Other DisordersOlivia C LaMonte, Steven R FeldmanDermatology Online Journal|November 19, 2019
Unilateral contact dermatitis of the chestLeena T Ramani, Steven R FeldmanJournal of Drugs in Dermatology : JDD|May 9, 2013
Combination therapy for psoriasis in the United StatesScott A Davis, Steven R FeldmanThe Journal of Dermatological Treatment|November 1, 2013
Patterns of ambulatory care usage and leading treatments for rosaceaScott A Davis, Steven R FeldmanPageof 93